Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
1999 2
2002 3
2003 3
2004 3
2005 5
2006 9
2007 13
2008 16
2009 17
2010 12
2011 15
2012 22
2013 23
2014 32
2015 31
2016 23
2017 28
2018 18
2019 16
2020 14
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 23108552

273 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Pertwee RG. Pertwee RG. Philos Trans R Soc Lond B Biol Sci. 2012 Dec 5;367(1607):3353-63. doi: 10.1098/rstb.2011.0381. Philos Trans R Soc Lond B Biol Sci. 2012. PMID: 23108552 Free PMC article. Review.
Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
Pertwee RG. Pertwee RG. Br J Pharmacol. 2009 Feb;156(3):397-411. doi: 10.1111/j.1476-5381.2008.00048.x. Br J Pharmacol. 2009. PMID: 19226257 Free PMC article. Review.
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ⁹-THC.
Coskun ZM, Bolkent S. Coskun ZM, et al. Cell Biochem Funct. 2014 Oct;32(7):612-9. doi: 10.1002/cbf.3058. Epub 2014 Sep 3. Cell Biochem Funct. 2014. PMID: 25187240
Endocannabinoids and Their Pharmacological Actions.
Pertwee RG. Pertwee RG. Handb Exp Pharmacol. 2015;231:1-37. doi: 10.1007/978-3-319-20825-1_1. Handb Exp Pharmacol. 2015. PMID: 26408156 Review.
Latest advances in cannabinoid receptor agonists.
Thakur GA, Tichkule R, Bajaj S, Makriyannis A. Thakur GA, et al. Expert Opin Ther Pat. 2009 Dec;19(12):1647-73. doi: 10.1517/13543770903436505. Expert Opin Ther Pat. 2009. PMID: 19939187 Review.
The pharmacology of cannabinoid receptors and their ligands: an overview.
Pertwee RG. Pertwee RG. Int J Obes (Lond). 2006 Apr;30 Suppl 1:S13-8. doi: 10.1038/sj.ijo.0803272. Int J Obes (Lond). 2006. PMID: 16570099 Free article. Review.
Cannabinoids and the expanded endocannabinoid system in neurological disorders.
Cristino L, Bisogno T, Di Marzo V. Cristino L, et al. Nat Rev Neurol. 2020 Jan;16(1):9-29. doi: 10.1038/s41582-019-0284-z. Epub 2019 Dec 12. Nat Rev Neurol. 2020. PMID: 31831863 Review.
Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
Deng L, Guindon J, Cornett BL, Makriyannis A, Mackie K, Hohmann AG. Deng L, et al. Biol Psychiatry. 2015 Mar 1;77(5):475-87. doi: 10.1016/j.biopsych.2014.04.009. Epub 2014 Apr 25. Biol Psychiatry. 2015. PMID: 24853387 Free PMC article.
Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond.
Pertwee RG. Pertwee RG. Addict Biol. 2008 Jun;13(2):147-59. doi: 10.1111/j.1369-1600.2008.00108.x. Addict Biol. 2008. PMID: 18482430 Review.
Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
Valdeolivas S, Satta V, Pertwee RG, Fernández-Ruiz J, Sagredo O. Valdeolivas S, et al. ACS Chem Neurosci. 2012 May 16;3(5):400-6. doi: 10.1021/cn200114w. Epub 2012 Feb 9. ACS Chem Neurosci. 2012. PMID: 22860209 Free PMC article.
273 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback